Aldeyra Therapeutics, Inc. (ALDX)
5.22
+0.23
(+4.61%)
USD |
NASDAQ |
Jan 22, 16:00
5.23
+0.01
(+0.19%)
After-Hours: 20:00
Aldeyra Therapeutics Research and Development Expense (TTM): 35.99M for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Vanda Pharmaceuticals, Inc. | 100.10M |
| ADMA Biologics, Inc. | 3.776M |
| Exelixis, Inc. | 860.76M |
| Altimmune, Inc. | 67.72M |
| Actinium Pharmaceuticals, Inc. | 20.82M |